Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action

Jessica Howell; Troy Combo; Paula Binks; Kylie Bragg; Sarah Bukulatjpi; Kirsty Campbell; Paul J. Clark; Melissa Carroll; Jane Davies; Teresa de Santis; Kate R. Muller; Bella Nguyen; John K. Olynyk; Nicholas Shackel; Patricia C. Valery; Alan J. Wigg; Jacob George; Stuart K. Roberts

doi:10.5694/mja2.52395

Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action

Jessica Howell, Troy Combo, Paula Binks, Kylie Bragg, Sarah Bukulatjpi, Kirsty Campbell, Paul J. Clark, Melissa Carroll, Jane Davies, Teresa de Santis, Kate R. Muller, Bella Nguyen, John K. Olynyk, Nicholas Shackel, Patricia C. Valery, Alan J. Wigg, Jacob George, Stuart K. Roberts

College of Medicine and Public Health

Research output: Contribution to journal › Article › peer-review

7 Downloads (Pure)

Abstract

Every year, about 1800 Australians die of hepatocellular carcinoma (HCC), the most common type of primary liver cancer.

Aboriginal and Torres Strait Islander peoples of Australia (hereon respectfully referred to as First Nations Australians) are 2.5 times more likely to develop HCC and 1.4 times more likely to die from HCC than non-Indigenous Australians.

First Nations Australians with HCC have a 9% five-year survival rate compared with 23% for non-Indigenous Australians,2 and are half as likely to be diagnosed with early-stage HCC and receive curative therapy.2 This is driven by First Nations Australians being adversely affected by social, cultural and commercial determinants of health stemming from colonisation, racism and remoteness.

Original language	English
Pages (from-to)	230-235
Number of pages	6
Journal	Medical Journal of Australia
Volume	221
Issue number	5
Early online date	6 Aug 2024
DOIs	https://doi.org/10.5694/mja2.52395
Publication status	Published - 2 Sept 2024

Keywords

hepatocellular carcinoma
First Nations Australians
liver cancer
Determinants of health and social inequalities.
Chronic liver disease

Access to Document

10.5694/mja2.52395Licence: CC BY-NC-ND

Final published versionFinal published version, 628 KBLicence: CC BY-NC-ND

Cite this

Howell, J., Combo, T., Binks, P., Bragg, K., Bukulatjpi, S., Campbell, K., Clark, P. J., Carroll, M., Davies, J., de Santis, T., Muller, K. R., Nguyen, B., Olynyk, J. K., Shackel, N., Valery, P. C., Wigg, A. J., George, J., & Roberts, S. K. (2024). Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action. Medical Journal of Australia, 221(5), 230-235. https://doi.org/10.5694/mja2.52395

@article{59529edec8884a0496075d76165f03fa,

title = "Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action",

abstract = "Every year, about 1800 Australians die of hepatocellular carcinoma (HCC), the most common type of primary liver cancer.Aboriginal and Torres Strait Islander peoples of Australia (hereon respectfully referred to as First Nations Australians) are 2.5 times more likely to develop HCC and 1.4 times more likely to die from HCC than non-Indigenous Australians.First Nations Australians with HCC have a 9% five-year survival rate compared with 23% for non-Indigenous Australians,2 and are half as likely to be diagnosed with early-stage HCC and receive curative therapy.2 This is driven by First Nations Australians being adversely affected by social, cultural and commercial determinants of health stemming from colonisation, racism and remoteness.",

keywords = "hepatocellular carcinoma, First Nations Australians, liver cancer, Determinants of health and social inequalities., Chronic liver disease",

author = "Jessica Howell and Troy Combo and Paula Binks and Kylie Bragg and Sarah Bukulatjpi and Kirsty Campbell and Clark, {Paul J.} and Melissa Carroll and Jane Davies and {de Santis}, Teresa and Muller, {Kate R.} and Bella Nguyen and Olynyk, {John K.} and Nicholas Shackel and Valery, {Patricia C.} and Wigg, {Alan J.} and Jacob George and Roberts, {Stuart K.}",

year = "2024",

month = sep,

day = "2",

doi = "10.5694/mja2.52395",

language = "English",

volume = "221",

pages = "230--235",

journal = "Medical Journal of Australia",

issn = "0025-729X",

publisher = "Australasian Medical Publishing Company Ltd.",

number = "5",

}

Howell, J, Combo, T, Binks, P, Bragg, K, Bukulatjpi, S, Campbell, K, Clark, PJ, Carroll, M, Davies, J, de Santis, T, Muller, KR, Nguyen, B, Olynyk, JK, Shackel, N, Valery, PC, Wigg, AJ, George, J & Roberts, SK 2024, 'Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action', Medical Journal of Australia, vol. 221, no. 5, pp. 230-235. https://doi.org/10.5694/mja2.52395

TY - JOUR

T1 - Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians

T2 - a strategic plan for action

AU - Howell, Jessica

AU - Combo, Troy

AU - Binks, Paula

AU - Bragg, Kylie

AU - Bukulatjpi, Sarah

AU - Campbell, Kirsty

AU - Clark, Paul J.

AU - Carroll, Melissa

AU - Davies, Jane

AU - de Santis, Teresa

AU - Muller, Kate R.

AU - Nguyen, Bella

AU - Olynyk, John K.

AU - Shackel, Nicholas

AU - Valery, Patricia C.

AU - Wigg, Alan J.

AU - George, Jacob

AU - Roberts, Stuart K.

PY - 2024/9/2

Y1 - 2024/9/2

N2 - Every year, about 1800 Australians die of hepatocellular carcinoma (HCC), the most common type of primary liver cancer.Aboriginal and Torres Strait Islander peoples of Australia (hereon respectfully referred to as First Nations Australians) are 2.5 times more likely to develop HCC and 1.4 times more likely to die from HCC than non-Indigenous Australians.First Nations Australians with HCC have a 9% five-year survival rate compared with 23% for non-Indigenous Australians,2 and are half as likely to be diagnosed with early-stage HCC and receive curative therapy.2 This is driven by First Nations Australians being adversely affected by social, cultural and commercial determinants of health stemming from colonisation, racism and remoteness.

AB - Every year, about 1800 Australians die of hepatocellular carcinoma (HCC), the most common type of primary liver cancer.Aboriginal and Torres Strait Islander peoples of Australia (hereon respectfully referred to as First Nations Australians) are 2.5 times more likely to develop HCC and 1.4 times more likely to die from HCC than non-Indigenous Australians.First Nations Australians with HCC have a 9% five-year survival rate compared with 23% for non-Indigenous Australians,2 and are half as likely to be diagnosed with early-stage HCC and receive curative therapy.2 This is driven by First Nations Australians being adversely affected by social, cultural and commercial determinants of health stemming from colonisation, racism and remoteness.

KW - hepatocellular carcinoma

KW - First Nations Australians

KW - liver cancer

KW - Determinants of health and social inequalities.

KW - Chronic liver disease

UR - http://www.scopus.com/inward/record.url?scp=85200505110&partnerID=8YFLogxK

U2 - 10.5694/mja2.52395

DO - 10.5694/mja2.52395

M3 - Article

AN - SCOPUS:85200505110

SN - 0025-729X

VL - 221

SP - 230

EP - 235

JO - Medical Journal of Australia

JF - Medical Journal of Australia

IS - 5

ER -

Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this